Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson’s Disease Model by Alleviating Mitochondrial Dysfunction
Yulia Aleksandrova, Kirill Chaprov, Alexandra V. Podturkina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5842-5842
Open Access | Times Cited: 10

Showing 10 citing articles:

New insights into the role of mitochondrial dynamics in oxidative stress-induced diseases
Sisi Chen, Qilong Li, Hanjing Shi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117084-117084
Open Access | Times Cited: 35
The chemistry of heterocycles in the 21st century
Valery N. Charushin, Egor V. Verbitskiy, О. Н. Чупахин, et al.
Russian Chemical Reviews (2024) Vol. 93, Iss. 7, pp. RCR5125-RCR5125
Closed Access | Times Cited: 28
3-N-butylphthalide attenuates neuroinflammation in rotenone-induced Parkinson’s disease models via the cGAS-STING pathway
Yuqian Liu, Ruonan Duan, Peizheng Li, et al.
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access | Times Cited: 7
Antioxidant and neuroprotection properties are involved in the anti-Parkinson potential of plumbagin and resveratrol in rotenone-induced Parkinson-like conditions
Prashant Amale, Arti Shriwas, Shilpa Deshpande
Next research. (2025), pp. 100131-100131
Closed Access
Elaboration of the Effective Multi-Target Therapeutic Platform for the Treatment of Alzheimer’s Disease Based on Novel Monoterpene-Derived Hydroxamic Acids
Yulia Aleksandrova, Aldar A. Munkuev, Evgenii S. Mozhaitsev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9743-9743
Open Access | Times Cited: 5
Therapeutic Potential of Myrtenal and Its Derivatives—A Review
Stela Dragomanova, Velichka Andonova, Константин П. Волчо, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2086-2086
Open Access | Times Cited: 5
Chemical composition and studying the possible neuroprotective effect of iridoids-rich fraction from Pentas lanceolata leaves using rotenone model of Parkinson’s disease in mice
Ahmed H. Afifi, Heba-tollah M. Sweelam, Marwa El-Sayed El-Shamarka, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 6, pp. 3953-3971
Open Access
Neuroprotective Effects and Cognitive Enhancement of Allomargaritarine in 5xFAD Alzheimer's Disease Mice Model
Yulia Aleksandrova, А. В. Семаков, Dmitry Tsypyshev, et al.
OBM Neurobiology (2024) Vol. 08, Iss. 01, pp. 1-33
Open Access
Inhibitory Activity of N- and S-Functionalized Monoterpene Diols Towards Monoamine Oxidases A and B
Alexandra V. Podturkina, Oleg V. Ardashov, Yu. V. Soldatova, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 97-97
Open Access
3-N-Butylphthalide Attenuates the Neuroinflammation in Rotenone-Induced Parkinson’s Disease Models via the cGas/STING Pathway
Yuqian Liu, Ruonan Duan, Peizheng Li, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top